Navigation Links
Nils Bergenhem, PhD - Newly Appointed President and Chief Scientific Officer of Egenix, Inc.
Date:7/22/2011

MILLBROOK, N.Y., July 22, 2011 /PRNewswire/ -- Egenix, Inc. -- Donald Fresne, CEO of Egenix, announced that the board approved the appointment of Nils Bergenhem, PhD as President and Chief Scientific Officer.  Dr. Bergenhem brings 16 years of drug development experience to the company and has successfully built and maintained international drug-discovery collaborations between equally-sized companies, as well as between biotech and major pharmaceutical companies.  Two out of three collaborations produced drug candidates moving into clinical development.  He was Vice President of Research & Development, and Chief Scientific Officer at CPEX Pharmaceuticals, Inc, an emerging specialty pharmaceutical company focused on the development, licensing and commercialization of pharmaceutical products prior to its sale early this year.  He previously held leadership positions at Escoublac, Inc, Adipogenix, Inc, the Institute for Diabetes Discovery, and OSI Pharmaceuticals.  Dr. Bergenhem received his B.S. in Chemistry at Linkoping University and Ph.D. in Biochemistry from Umea University in Sweden.

"Egenix approach to treating cancer has the potential to prevent uncontrolled cancerous cell growth, while not affecting normally growing cells," said Nils Bergenhem.  "I am very excited to join Egenix, and help drive these programs forward to clinical application."

About Egenix, Inc:

Egenix is a privately held, New York-based biotechnology company focused on the development of innovative cancer therapeutics. The company's therapeutic platform technology consists of small molecule drugs applicable for the treatment and prevention of a broad spectrum of cancers. Our lead drug candidates inhibit the "translation initiation factors" eIF4E and eIF2a, specifically blocking production of multiple cancer promoting proteins and promoting apoptosis (programmed cell death) and upregulation of tumor suppressor genes.
'/>"/>

SOURCE Egenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Newly Published Study Showed Axiron® (testosterone) Topical Solution Restored Testosterone Levels to Normal Range in Hypogonadal Men
2. The Newly Combined Axcan and Eurand Announce Name Change to Aptalis
3. Global Pharm Holdings Group Obtains Business License for its Newly Established Joint-Venture in Jinan City
4. MedVantx and Blue Cross & Blue Shield of Rhode Island Partner to Provide Physicians with Integrated Medication Management Platform in Newly Created Patient-Centered Medical Homes
5. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
6. Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients
7. Zimmer Showcases Newly Acquired Line of Surgical Power Tools at 2011 AAOS Annual Meeting
8. Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study
9. Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients
10. Apollo Endosurgery Demonstrates Clinical Functionality of the Newly Launched OverStitch™ Endoscopic Suturing System in Bariatric Repairs and GI Therapy
11. Capital BlueCross Newly Designed Health Care Reform Web Portal Features New Videos, Interactive Tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... N.C. , Oct. 24, 2014 ... provide Medical Affairs leaders with a forum for ... The consortium has developed a mechanism for creating ... where leaders discuss key findings from the Medical ... has completed the analysis for the first roundtable ...
(Date:10/22/2014)... , Oct. 22, 2014  Cephasonics, a technology-innovation ... introduction of the cQUB™-1 (cQuest Ultrasound Box™-1), the first ... systems designed and manufactured by Cephasonics for purchase by ... model number. Cephasonics will be showcasing the cQUB-1 for ... this week in Chongqing, China ...
(Date:10/22/2014)... Investor-Edge has initiated coverage on the following ... Progenics Pharmaceuticals Inc. (NASDAQ: PGNX ), Threshold ... Inc. (NASDAQ: IDRA ), and Merrimack Pharmaceuticals ... can be accessed at: http://investor-edge.com/register . ... at 4,419.48, up 2.40%, the Dow Jones Industrial Average ...
Breaking Medicine Technology:Strong Participation in Best Practices' Medical Affairs Consortium Survey 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5
(Date:10/22/2014)... 22, 2014 On October 22, CBS ... featuring skin diseases both fictional and real. The ... nonprofit organization committed to advocacy and philanthropy in the ... take the opportunity to impart truth and clarity about ... There are many misconceptions about Morgellons Disease ...
(Date:10/22/2014)... 22, 2014 Isabel Healthcare ... Health Professions (ASAHP) Conference on October 22-24 in Las ... participate in a panel discussion on Technology in Health ... Healthcare provides a diagnostic decision support tool and clinical ... skills of students and clinical learners. The Isabel tools ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... in Dallas. But, mental health specialists say overblown fear is ... Obama on Friday appointed an Ebola "czar" to oversee the ... nurses who cared for a Liberian man who died of ... the U.S. cases are miniscule in the context of the ...
(Date:10/22/2014)... Shriners Hospitals for Children® and UK HealthCare ... location of Shriners Hospitals for Children - Lexington from ... University of Kentucky Albert B. Chandler Hospital. The new ... and operated by Shriners Hospitals for Children, and designed ... their families well into the future. , “The quality ...
(Date:10/22/2014)... 22, 2014 Hay House is pleased to ... and Upgrade Your Life (Paperback; $10.82) written by the highly ... Recovery. This book is meant to help readers of ... of recovery. , Recovery 2.0 is not the average ... 2.0 is a guide for what comes next. ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3
... war veterans, a friendly bartender can be the source of ... pilot study suggests that some bartenders may be in a ... services and help connect them to the appropriate agency. ... Veterans of Foreign Wars posts in Ohio. The results ...
... supplies of safe and reliable human embryonic stem (hES) ... field has faced challenges in developing cultures that can ... Standard culture systems use mouse "feeder" cells and ... cells, but such animal productbased media can contaminate the ...
... 2011) A new study led by researchers at ... Hospital and Colorado Health Outcomes Program (COHO) at the ... facilitators and alternative approaches to providers sending reminder ... or recall messages, usually in the form of postcards, ...
... 25 (HealthDay News) -- Elderly patients with dementia and ... often do not comprehend why they are there and ... a new study finds. U.S. researchers interviewed 202 ... department and found that those with cognitive impairment (dementia ...
... their clinics by further developing a culture of safety in ... errors and can work together to maximize safety, according to ... Radiation Oncology (PRO), a new medical journal whose mission ... is an official journal of the American Society for Radiation ...
... EDITOR,S PICK: Possible new approach to treating a life-threatening ... is a life-threatening disease of the blood system. The ... of the protein von Willebrand factor, which promote the ... throughout the body. Current treatments are protracted and associated ...
Cached Medicine News:Health News:Bartenders may have role in assisting troubled war veterans 2Health News:Bartenders may have role in assisting troubled war veterans 3Health News:UCLA researchers eliminate major roadblock in regenerative medicine 2Health News:UCLA researchers eliminate major roadblock in regenerative medicine 3Health News:New study finds reminders for immunizations challenging for pediatric practices 2Health News:New study finds reminders for immunizations challenging for pediatric practices 3Health News:Elderly With Dementia, Delirium Confused by ER Visits: Study 2Health News:Culture of safety key to reducing chances for medical errors 2Health News:JCI table of contents: Jan. 25, 2011 2Health News:JCI table of contents: Jan. 25, 2011 3Health News:JCI table of contents: Jan. 25, 2011 4Health News:JCI table of contents: Jan. 25, 2011 5Health News:JCI table of contents: Jan. 25, 2011 6Health News:JCI table of contents: Jan. 25, 2011 7Health News:JCI table of contents: Jan. 25, 2011 8
0.5 mm, 1 x 2 teeth set at 45 degrees and 6 mm tying platform. Serrated handle with polished finish....
Two 2.75 mm long tips separated 1 mm with 1 x 2 teeth. Serrated handle with dull finish....
1 x 2 teeth and 5.5 mm tying platform. Round knurled handle with polished finish. Teeth: 0.3 mm....
Colibri style tips with 0.12 mm, 1 x 2 teeth. Round knurled handle with alignment pin and polished finish....
Medicine Products: